Showing results (191-200 of 757) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
The Lancet. Gastroenterology & Hepatology|March 21, 2021
Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health systemMeiwen Zhang, Daniel O'Keefe, Jennifer Craig, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2021
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a studyKenneth Cusi, Naim Alkhouri, Stephen A Harrison, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
The Lancet. Gastroenterology & Hepatology|October 25, 2021
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trialDavid Tai, Kelvin Loke, Apoorva Gogna, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2019
Comorbidities in inflammatory bowel disease: a call for actionMarjorie Argollo, Daniela Gilardi, Carina Peyrin-Biroulet, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2019
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trialQiuhe Wang, Kai Li, Chuangye He, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2022
Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the LiverSamuel Shribman, Thomas Marjot, Abubakar Sharif, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Liang Kang, Jianwei Zhang, et al.
The Lancet. Gastroenterology & Hepatology|April 2, 2022
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyKatsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, et al.
Pageof 76